Globus Medical (GMED) Form 144: 10,000 Shares Proposed Sale $584K

Form 144 notice for Globus Medical, Inc. (GMED) reports a proposed sale of 10,000 shares of common stock through Raymond James & Associates on the NYSE with an approximate aggregate market value of $584,000.

Rhea-AI Filing Summary

Form 144 notice for Globus Medical, Inc. (GMED) reports a proposed sale of 10,000 shares of common stock through Raymond James & Associates on the NYSE with an approximate aggregate market value of $584,000. The filer shows the securities were acquired and are to be sold on 09/15/2025 pursuant to a cashless stock option, with payment and acquisition both recorded on that date. The filing lists 98,254,456 shares outstanding for the issuer. The filer attests they do not possess undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.

Insights

Securities Analyst

TL;DR: A routine insider sale via cashless option; size is immaterial relative to shares outstanding.

The notice documents an insider or related person's intended disposition of 10,000 shares valued at $584,000 via Raymond James on 09/15/2025, funded by a cashless exercise of stock options. Against total outstanding shares of 98,254,456 the position represents a de minimis percentage, so this filing is unlikely to be material to market valuation. The representation regarding lack of undisclosed material information and the Rule 10b5-1 language is standard and reduces regulatory ambiguity.

Corporate Governance Expert

TL;DR: Compliance appears standard; disclosures and attestations align with typical Rule 144 and 10b5-1 procedures.

The form specifies acquisition and sale via cashless stock option on the same date, which is a common method for executives to monetize option value. Presence of broker details and the seller's attestation about material nonpublic information follows best practices. No unusual clauses, trading-plan dates, or multiple recent sales are disclosed, limiting governance concerns from this filing alone.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for Globus Medical (GMED) disclose?

The filing discloses a proposed sale of 10,000 common shares via Raymond James on 09/15/2025, acquired and to be sold under a cashless stock option, valued at $584,000.

How large is the proposed sale relative to GMED's outstanding shares?

The filing reports 98,254,456 shares outstanding; 10,000 shares represent a de minimis percentage of the outstanding share count.

Was the sale part of a trading plan under Rule 10b5-1?

The form includes the standard Rule 10b5-1/trading-plan notice language but does not provide a plan adoption date in the remarks section.

Who is the broker handling the proposed sale on GMED's Form 144?

The broker named is Raymond James & Associates located at 880 Carillon Parkway, St. Petersburg, FL; the exchange listed is the NYSE.

Does the filing report any other securities sold in the past three months?

No; the filing states 'Nothing to Report' for securities sold during the past three months for the person whose account is being sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/15/2025 - 03:51 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001250252
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	RHOADS ANN D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	10000	584000.00	98254456	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Cashless Stock Option	Issuer			10000	09/15/2025	Cashless Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/08/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Ann D Rhoads
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)